Where do Krystal Biotech, Inc.'s ratios come from?

Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	42.8%+10.2pp	41.4%+18.8pp	42.4%+32.3pp	38.8%+53.3pp	32.6%+106pp
Net margin	53.9%+16.7pp	52.6%+21.9pp	53.3%+31.6pp	40.8%-22.9pp	37.2%-22.4pp
Returns
Return on equity	19.9%+6.0pp	18.9%+8.6pp	19.7%+13.3pp	15.6%+1.4pp	13.9%+5.0pp
Return on invested capital	24.3%+7.1pp	24%+12.2pp	24.8%+20.0pp	20.2%+25.6pp	17.2%+34.2pp
Efficiency
Asset turnover	0.3×0.0×	0.3×0.0×	0.3×+0.1×	0.3×+0.1×	0.3×+0.2×
Liquidity
Current ratio	9.5×-0.2×	10×+2.7×	10.1×+2.2×	9.7×+0.2×	9.6×-3.0×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.7×-0.1×	-2.9×+1.8×	-2.3×+9.7×	-2.4×—	-2.6×—
Per Share
Book value per share	$41.85+27.0%	$40.72+28.0%	$38.14+28.7%	$34.98+23.6%	$32.96+20.8%
Valuation
Market capitalization	$7.55B+45.4%	$7.15B+58.7%	$5.11B-1.9%	$4.15B-20.1%	$5.19B+3.2%
Price / earnings	33.6×-8.3×	34.9×-15.6×	25.7×-73.7×	28.3×-20.8×	41.9×-46.2×
Price / sales	18.1×+2.5×	18.4×+2.9×	13.7×-7.9×	11.6×-19.7×	15.6×-36.9×
Price / book	5.9×+0.6×	5.9×+1.1×	4.5×-1.4×	4×-2.2×	5.3×-1.0×
EV / EBITDA	38.3×-4.5×	39.9×-18.3×	28.9×-130×	26.3×—	42.7×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Krystal Biotech, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Krystal Biotech, Inc.'s ratios come from?: Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.